M&A Deal Summary |
|
|---|---|
| Date | 2021-11-17 |
| Target | Cardioline |
| Sector | Medical Products |
| Buyer(s) | ArchiMed |
| Deal Type | Buyout (LBO, MBO, MBI) |
| Advisor(s) | Brown Gibbons Lang (BGL) (Financial) |
SEARCH BY
ArchiMed is a specialist French private equity firm focused on buyouts of and growth capital investments in European healthcare-oriented companies. The Firm looks to invest €10 million to €1 billion per transaction and specifically targets companies in the public health, care and wellness, biotech, and medical technology segments of the healthcare industry. ArchiMed was formed in 2014 and is headquartered in Lyon.
| DEAL STATS | # |
|---|---|
| Overall | 26 of 38 |
| Sector: Medical Products M&A | 8 of 9 |
| Type: Buyout (LBO, MBO, MBI) M&A Deals | 17 of 21 |
| Country: Italy M&A | 5 of 6 |
| Year: 2021 M&A | 7 of 9 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-11-03 |
Cube Biotech
Monheim, Germany Cube Biotech provides dedicated services and collaborations for membrane protein applications that facilitate structure-based drug design Expression (in pro-and eukaryotic systems and cell-free), Purification (using standard tags and customized affinity chromatography, and Crystallization (using vapour diffusion, LCP, and proprietary CIMP methods). The company's raw materials are sourced from selected suppliers committed to the highest quality standards. Many consumables that are used in service are provided to the community, accompanied by dedicated protocols and handbooks, as well as tips and tricks for success. Cube Biotech was formed in 2012 and is based in Monheim, Germany. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-11-18 |
Suanfarma
Alcobendas, Spain Suanfarma is a provider in developing, producing, and marketing raw materials and finished dosage forms for the pharmaceutical, biotechnological, veterinary, nutritional, and cosmetic sectors. Suanfarma was founded in 1993 and is based in Alcobendas, Spain. |
Buy | - |
